Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents

Annals of Thoracic Medicine

Volumn 5, Issue 2, 2010, Pages 92-96

  Edis, Ebru Cakir ^a   Hatipoglu, Osman N ^a   Tansel, Ozlem ^b   Sut, Necdet ^b  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Acinetobacter spp.; hospital acquired pneumonia; risk factors; survival; therapeutic success

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYTOSTATIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; SEDATIVE AGENT;

ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL INFECTION; HUMAN; HYPOALBUMINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPIRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 77956023741     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.62472     Document Type: Article

References (18)

1. Hartzell JD, Kim AS, Kortepeter MG, Moran KA. Acinetobacter pneumonia: A review. Med Gen Med 2007;9:4.
2. Luna CM, Aruj PK. Nosocomial Acinetobacter pneumonia. Respirology 2007;12:787-791
3. Garnacho-Montero J, Ortiz- Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, et al. Acinetobacter baumanni ventilator- associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 2005;31:649-655
4. Medina J, Formento C, Pontet J, Curbelo A, Bazet C, Gerez J, et al. Prospective study of risk factors for ventilator-associated pneumonia caused by Acinetobacter species. J Crit Care 2007;22:18-26.
5. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
6. Turkish Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired pneumonia 2002. Turk Thorac J 2002;3:1-13.
7. Paterson DL. The epidemiologic profile of infections with multidrug-resistant Pseudonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006;43:43-48
8. Cakir Edis E, Hatipoglu ON, Yilmam I, Eker A, Tansel O, et al. Hospital-acquired pneumonia developed in non-intensive care units. Respiration 2009;78:416-422
9. Cisneros-Herreros JM, Garnacho-Montero J, Pachon-Ibanez ME. Nosocomial pneumonia due to Acinetobacter baumannii. Enferm Infecc Microbiol Clin 2005;23:46-51.
10. Baraibar J, Correa H, Mariscal D, Gallego M, Vallés J, Rello J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997;112:1050-1054
11. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-1382
12. Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, et al. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: Risk factors and outcomes. J Hosp Infect 2006;64:282-287
13. Gilad J, Carmeli Y. Treatment options for multidrug-resistant Acinetobacter species. Drugs 2008;68:165-189
14. Cakir Edis E, Caglar T, Otkun M, Gurcan M, Hatipoglu ON, et al. Causative agents of hospital-acquired pneumonia and their antimicrobial resistance. Turk J Infect 2006;20:107-110
15. Erdem I, Ozgultekin A, Sengoz Inan A, Dincer E, Turan G, Ceran N, et al. Incidence, etiology and antibotic resistance patterns of gram-negative microorganisms isolated from patients with ventilator- associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in Istanbul, Turkey (2004- 2006). Jpn J Infect Dis 2008;61:339-342
16. Albrecht MC, Griffith ME, Murray CK, Chung KK, Horvath EE, Ward JA, et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 2006;203:546-550
17. Falagas ME, Kopterides P, Siempos II. Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 2006;43:389.
18. Meric M, Willke A, Caglayan C, Toker K. Intensive care unit-acquired infections: Incidence, risk factors and associated mortality in a Turkish university hospital. Jpn J Infect Dis 2005;58:297-302.